MOESM1 of Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
datasetposted on 16.01.2020, 04:57 by Maria Koromina, Stefania Koutsilieri, George Patrinos
Additional file 1: Table S1. Summary information for the identified drug SNP-correlations. Table S2. List of the antipsychotic/antidepressant drug-SNP correlations that have been reported once (duplicates removed) in the assessed 20 studies deposited in the GWAS catalog.